International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response
Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
The overarching goal of the Master Protocol is to find effective strategies for inpatient
management of patients with COVID-19. Therapeutic goals for patients hospitalized for
COVID-19 include hastening recovery and preventing progression to critical illness,
multiorgan failure, or death. Our objective is to determine whether modulating the host
tissue response improves clinical outcomes among patients with COVID-19.